These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28992165)

  • 21. Validation of disease activity indices using the 28 joint counts in systemic sclerosis.
    Lóránd V; Bálint Z; Komjáti D; Németh B; Minier T; Kumánovics G; Farkas N; Czirják L; Varjú C;
    Rheumatology (Oxford); 2016 Oct; 55(10):1849-58. PubMed ID: 27402873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale.
    Sibeoni J; Dunogué B; Dupont A; Haiddar D; Benmostefa N; Falissard B; Mouthon L; Révah-Levy A; Verneuil L
    Br J Dermatol; 2022 Jan; 186(1):96-105. PubMed ID: 34355380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of a home-based program for hands in patients with systemic sclerosis.
    Landim SF; Bertolo MB; Marcatto de Abreu MF; Del Rio AP; Mazon CC; Marques-Neto JF; Poole JL; de Paiva Magalhães E
    J Hand Ther; 2019; 32(3):313-321. PubMed ID: 29198478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability, Validity, and Sensitivity to Change of the Cochin Hand Functional Disability Scale and Testing the New 6-Item Cochin Hand Functional Disability Scale in Systemic Sclerosis.
    Gheorghiu AM; Gyorfi H; Capotă R; Matei A; Oneaţă R; Bojincă M; Stoica V; Mihai C
    J Clin Rheumatol; 2021 Apr; 27(3):102-106. PubMed ID: 31703022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cultural adaptation, translation and validation of Cochin Hand Function Scale and evaluation of hand dysfunction in systemic sclerosis.
    Bairwa D; Kavadichanda CG; Adarsh MB; Gopal A; Negi VS
    Clin Rheumatol; 2021 May; 40(5):1913-1922. PubMed ID: 33063134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients.
    Cole JC; Khanna D; Clements PJ; Seibold JR; Tashkin DP; Paulus HE; Irwin MR; Motivala SJ; Furst DE
    Qual Life Res; 2006 Oct; 15(8):1383-94. PubMed ID: 16826439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
    Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a tailored rehabilitation program for systemic sclerosis.
    Maddali Bongi S; Del Rosso A; Galluccio F; Tai G; Sigismondi F; Passalacqua M; Landi G; Baccini M; Conforti ML; Miniati I; Matucci-Cerinic M
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):44-50. PubMed ID: 19796561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in patients with systemic sclerosis recruited from associations and tertiary care settings.
    Mestre-Stanislas C; Poiraudeau S; Berezné A; Rannou F; Pagnoux C; Revel M; Guillevin L; Mouthon L
    Presse Med; 2010 Sep; 39(9):e205-9. PubMed ID: 20356709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials.
    Humbert M; Singh M; Furst DE; Khanna D; Seibold JR
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v33-v37. PubMed ID: 28992168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.
    Maddali-Bongi S; Del Rosso A; Mikhaylova S; Francini B; Branchi A; Baccini M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-15-20. PubMed ID: 24850211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis--measuring functional impairment in systemic sclerosis versus other connective tissue diseases.
    Morita Y; Muro Y; Sugiura K; Tomita Y; Tamakoshi K
    Clin Exp Rheumatol; 2007; 25(3):367-72. PubMed ID: 17631731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.
    Kuwana M; Sato S; Kikuchi K; Kawaguchi Y; Fujisaku A; Misaki Y; Hatamochi A; Kondo H; Takehara K
    J Rheumatol; 2003 Jun; 30(6):1253-8. PubMed ID: 12784399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial of wax baths as an additive therapy to hand exercises in patients with systemic sclerosis.
    Gregory WJ; Wilkinson J; Herrick AL
    Physiotherapy; 2019 Sep; 105(3):370-377. PubMed ID: 30318128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties.
    Johnson SR; Hawker GA; Davis AM
    Arthritis Rheum; 2005 Apr; 53(2):256-62. PubMed ID: 15818719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis.
    Lumetti F; Barone L; Alfieri C; Silva M; Serra V; Delsante G; Sverzellati N; Ariani A
    Acta Biomed; 2015 Sep; 86(2):142-8. PubMed ID: 26422428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.